Ranbaxy Labs is anticipated to report a PAT of Rs 140 cr in the 3rd qtr

Pharmaceutical company Ranbaxy Labs is anticipated to report a PAT of Rs 140 cr in the 3rd qtr of 2011 compared to Rs 308 cr in a yr ago period.

Income are seen rising 8percent to Rs 2,091 cr compared to Rs 1,935 cr while the similar period.

EBITDA is likely to bounce 28percent to Rs 177 cr in July-September qtr of 2011 compared to Rs 139 cr in the similar qtr of last financial.

Operating_profit margin is anticipated to be at 8.5percent compared to 7percent yoy.

Be Sociable, Share!

Stock Market Basics For Beginners

Investment Definition

Investment Definition Investment means; investing money in property, equity (stock and share), bonds and business or purchasing goods for making more money. Education and health Expenditure is ...…

Mutual Funds

Mutual Funds Why¬† you need a expert or a financial planner to select the funds & timely review them because even a 3% difference in the Portfolio ...…

Auction Market

Auction Market An auction¬† market is a good example of buying and selling of financial instruments (stocks) which happens on the floor of the exchange, such as ...…

The Equity Market

The Equity Market The Indian Equity Market is more commonly known as the Indian share Market. The Indian stock (share) market has become the third biggest after China ...…

Dematerialization Definition

Dematerialization Definition Dematerialization (Meaning) is the procedure through which physical certificates of the trader are usually transformed into an equal quantity of securities in electronic form as ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV